Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03447249
Brief Title: A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

First Submitted : February 21, 2018
First Submitted that Met QC Criteria : February 21, 2018
First Posted : February 27, 2018

Last Update Submitted that Met QC Criteria : March 6, 2019
Last Update Posted : March 8, 2019